Freedom Meditech, a medical device company commercializing non-invasive ophthalmic technologies for the detection of disease and management of patient health, has appointed Paul M. Karpecki, OD, FAAO, to the scientific advisory board.

"I am joining the scientific advisory board at an exciting time for the company as it prepares to introduce optometrists to ClearPath DS-120,” said Karpecki. “Detecting autofluorescence in the crystalline lens of the eye, which has been tied to biomarkers associated with diabetes, represents an important and valuable new health offering optometrists can consider during an eye exam."

Karpecki currently works in corneal services, heads the ocular surface disease clinic and is director of clinical research at the Koffler Vision Group in Lexington, Ky. Karpecki was one of two optometrists appointed to the Delphi International Society at Wilmer-Johns Hopkins, which included the top 25 dry eye experts in the world, and the National Eye Institute's Dry Eye Committee. Karpecki is the chief medical editor and vice president of clinical content for the Review of Optometry journal.  He also serves on the board for the charitable organization Optometry Giving Sight.

Dr. Karpecki has lectured in over 400 symposia covering four continents. He also has served as past president of the optometric council on refractive technology, chair of the refractive surgery advisory board to the American Optometric Association (AOA), chairman of the topical interest group in refractive surgery, chairman of the American Society of Cataract and Refractive Surgeon's Task Force on the integrated eyecare delivery system, chairman of the Kentucky Optometric Association Education Committee and the AOA Congress Education Committee.